|
Biel, Nikolett M; Siemann, Dietmar W (2016) Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference. Cancer Lett 380:525-33
|
|
Magdoom, Kulam Najmudeen; Pishko, Gregory L; Rice, Lori et al. (2014) MRI-based computational model of heterogeneous tracer transport following local infusion into a mouse hind limb tumor. PLoS One 9:e89594
|
|
Siemann, Dietmar W (2011) The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents. Cancer Treat Rev 37:63-74
|
|
Bertelsen, Lotte B; Shen, Yuan Yuan; Nielsen, Thomas et al. (2011) Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. Int J Radiat Biol 87:1126-34
|
|
Rice, Lori; Pampo, Christine; Lepler, Sharon et al. (2011) Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503. Microvasc Res 81:44-51
|
|
Madlambayan, Gerard J; Meacham, Amy M; Hosaka, Koji et al. (2010) Leukemia regression by vascular disruption and antiangiogenic therapy. Blood 116:1539-47
|
|
Wankhede, Mamta; Dedeugd, Casey; Siemann, Dietmar W et al. (2010) In vivo functional differences in microvascular response of 4T1 and Caki-1 tumors after treatment with OXi4503. Oncol Rep 23:685-92
|
|
Baguley, Bruce C; Siemann, Dietmar W (2010) Temporal aspects of the action of ASA404 (vadimezan; DMXAA). Expert Opin Investig Drugs 19:1413-25
|
|
Siemann, Dietmar W; Horsman, Michael R (2009) Vascular targeted therapies in oncology. Cell Tissue Res 335:241-8
|
|
Siemann, Dietmar W; Chaplin, David J; Walicke, Patricia A (2009) A review and update of the current status of the vasculature-disabling agent combretastatin-A4 phosphate (CA4P). Expert Opin Investig Drugs 18:189-97
|
Showing the most recent 10 out of 32 publications
